Incontinence - urinary, in women
Exam Tips
- Classify by trigger: stress (effort/cough), urgency (cannot defer), mixed (both); this drives first-line therapy.
- Always include red flags in history: haematuria, recurrent UTI, pain, constant leakage, prior pelvic surgery/radiotherapy, neurological deficits.
- In OSCE, perform cough stress test with a comfortably full bladder and document pelvic floor strength (for example Oxford scale).
- Request urine dip for every patient and send culture if infection likely; check post-void residual if voiding symptoms suggest retention.
- For prescribing stations, state key safety points: antimuscarinic cognitive burden/retention risk, mirabegron hypertension contraindication, duloxetine adverse-effect counselling.
- For anatomy revision, review pelvic floor and urethral support diagrams in your core urogynaecology text (endopelvic fascia, levator ani, and urethral sphincter complex).
Definition
Urinary incontinence in women is any involuntary loss of urine, and it is a symptom complex rather than a single disease. Clinically it is classified as stress, urgency (often with overactive bladder), mixed, overflow, or continuous incontinence, because mechanism and treatment differ by subtype.
Pathophysiology
Continence depends on coordinated detrusor relaxation/filling, urethral closure pressure, pelvic floor support, and intact neural control. Stress incontinence reflects urethral sphincter incompetence or loss of pelvic support, so rises in intra-abdominal pressure (cough/exertion) overcome outlet resistance. Urgency incontinence is usually due to detrusor overactivity (idiopathic or neurogenic), causing involuntary contractions during bladder filling. Mixed incontinence combines both outlet weakness and detrusor overactivity; overflow incontinence results from chronic retention due to outlet obstruction or detrusor underactivity. Ageing, menopause-related tissue change, obstetric pelvic floor injury, and comorbidity (for example diabetes or neurological disease) all shift this balance toward leakage.
Risk Factors
- Increasing age and postmenopausal status
- Pregnancy, multiparity, and vaginal delivery
- Obesity (raised chronic intra-abdominal pressure)
- Pelvic surgery (for example hysterectomy) or pelvic organ prolapse
- Neurological disease (stroke, Parkinson disease, multiple sclerosis, spinal pathology)
- Diabetes mellitus
- Recurrent urinary tract infection
- High caffeine or alcohol intake; very high or very low fluid intake
- Chronic cough/smoking and chronic constipation/straining
- Medicines that worsen symptoms (for example diuretics, alpha-blockers, anticholinergic load, sedatives/opioids)
Clinical Features
Symptoms
- Stress pattern: leakage with cough, sneeze, laugh, exercise, lifting
- Urgency pattern: sudden compelling urge, frequency, nocturia, urge leakage
- Mixed pattern: both stress-triggered and urgency-associated leakage
- Voiding difficulty, weak stream, straining, incomplete emptying (suggests overflow)
- Continuous leakage (consider fistula, severe sphincter failure, ectopic ureter)
- Associated impact: sleep disturbance, sexual dysfunction, embarrassment, social withdrawal, low mood
Signs
- Leakage seen at urethral meatus during cough stress test with comfortably full bladder
- Raised BMI or central obesity
- Palpable suprapubic bladder after voiding (retention/overflow clue)
- Pelvic organ prolapse, atrophic vulvovaginal change, or pelvic mass on examination
- Reduced pelvic floor contraction strength (for example low Oxford grade)
- Neurological abnormalities (gait, lower-limb neurology, perineal sensation/reflex deficits)
Investigations
Management
Lifestyle Modifications
- Explain subtype and use shared decision-making; set patient-centred goals and quantify baseline severity with bladder diary
- Supervised pelvic floor muscle training for at least 3 months (first-line for stress and mixed symptoms)
- Bladder training for at least 6 weeks for urgency/overactive bladder symptoms
- Weight reduction if overweight, smoking cessation, treat constipation and chronic cough
- Optimise fluid intake (avoid both over- and under-drinking), reduce caffeine and excess alcohol
- Review and rationalise contributory medicines where clinically safe (for example timing of diuretics, anticholinergic burden)
Pharmacological Treatment
Antimuscarinics for urgency incontinence/OAB
- Oxybutynin immediate-release 2.5 mg two to three times daily, titrate to 5 mg two to three times daily if tolerated
- Tolterodine immediate-release 2 mg twice daily (or modified-release 4 mg once daily)
- Solifenacin 5 mg once daily, may increase to 10 mg once daily
- Trospium 20 mg twice daily (reduce in renal impairment)
Use lowest effective dose and review benefit/side effects at 4-8 weeks. Class effects: dry mouth, constipation, blurred vision, cognitive adverse effects; caution in frailty and high anticholinergic burden. Contraindications/cautions include urinary retention, gastric retention, severe ulcerative colitis/toxic megacolon, and angle-closure glaucoma risk.
Beta-3 adrenoceptor agonist for urgency incontinence/OAB
- Mirabegron 50 mg once daily (reduce to 25 mg once daily in selected renal/hepatic impairment)
Useful when antimuscarinics are contraindicated or not tolerated. Monitor blood pressure. Contraindicated in severe uncontrolled hypertension (for example systolic >= 180 mmHg or diastolic >= 110 mmHg). Check interactions (CYP2D6 substrate effects) and renal/hepatic dosing limits.
Serotonin-noradrenaline reuptake inhibitor for stress incontinence (selected women)
- Duloxetine 40 mg twice daily (often started at 20 mg twice daily for 2 weeks to improve tolerability)
Consider only if surgery is unsuitable/declined and after discussing modest efficacy versus adverse effects. Common adverse effects: nausea, fatigue, insomnia. Avoid with severe hepatic impairment, severe renal impairment, uncontrolled hypertension, and use caution with suicidality risk and serotonergic interactions.
Topical vaginal oestrogen in postmenopausal urogenital atrophy with LUTS
- Estriol 0.01% vaginal cream 0.5 mg daily for 2-3 weeks then maintenance twice weekly
Improves atrophic symptoms and may reduce urgency/frequency; not a sole curative treatment for all incontinence. Do not use systemic HRT solely to treat urinary incontinence.
Surgical / Interventional
- Stress incontinence procedures after specialist assessment: colposuspension, autologous fascial sling, or retropubic mid-urethral sling with full mesh-risk counselling and local policy adherence
- Periurethral bulking agent injections for selected women (less invasive, often lower long-term efficacy)
- Refractory urgency incontinence/OAB: intradetrusor botulinum toxin A (commonly 100 units), sacral neuromodulation, or posterior tibial nerve stimulation
- Address structural causes such as fistula, significant prolapse, urethral diverticulum, or obstruction when present
Complications
- Anxiety, depression, low self-esteem, and reduced quality of life
- Sleep disturbance (especially with nocturia) and daytime fatigue
- Sexual dysfunction and relationship strain
- Skin irritation/breakdown and secondary infection
- Recurrent urinary tract infection
- Falls and functional decline, especially in older adults
- Social isolation, reduced work productivity, and financial burden from pads/laundry
Prognosis
Most women improve substantially with structured conservative therapy and targeted treatment by subtype, and many achieve meaningful symptom control rather than complete cure. Prognosis is poorer if major neurological disease, severe prolapse, untreated retention, or persistent contributory factors remain unaddressed.
Sources & References
🏥BMJ Best Practice(1)
💊BNF Drug References(6)
- Darifenacin[management.pharmacological]
- Fesoterodine fumarate[management.pharmacological]
- Oxybutynin hydrochloride[management.pharmacological]
- Solifenacin succinate[management.pharmacological]
- Tolterodine tartrate[management.pharmacological]
- Trospium chloride[management.pharmacological]
✅NICE Guidelines(1)
- Incontinence - urinary, in women[overview]
📖Textbook References(15)
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 969)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 988)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 271)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 271, 272)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1713)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 198)[context]
- [Oxford Medical Handbooks] Ian Wilkinson, Tim Raine, Kate Wiles, Anna Goodhart, Catriona Ha - Oxford Handbook of Clinical Medicine (2017, Oxford University Press) - libgen.li.pdf(pp. 858)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1332)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1331, 1332)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1379, 1380)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1334, 1335)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1382)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1302, 1303)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1264)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1380)[context]